190 related articles for article (PubMed ID: 30501642)
1. The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects.
Osuji FN; Onyenekwe CC; Ahaneku JE; Ukibe NR
J Biomed Sci; 2018 Dec; 25(1):88. PubMed ID: 30501642
[TBL] [Abstract][Full Text] [Related]
2. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
3. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
[TBL] [Abstract][Full Text] [Related]
4. Pro-Inflammatory Cytokine Levels in HIV Infected and Uninfected Pregnant Women with and without Preeclampsia.
Maharaj NR; Phulukdaree A; Nagiah S; Ramkaran P; Tiloke C; Chuturgoon AA
PLoS One; 2017; 12(1):e0170063. PubMed ID: 28095491
[TBL] [Abstract][Full Text] [Related]
5. Cytokine profiles in highly active antiretroviral treatment non-adherent, adherent and naive HIV-1 infected patients in Western Kenya.
Musa F; Shaviya N; Mambo F; Abonyo C; Barasa E; Wafula P; Sowayi G; Barasa M; Were T
Afr Health Sci; 2021 Dec; 21(4):1584-1592. PubMed ID: 35283948
[TBL] [Abstract][Full Text] [Related]
6. HIV DNA and immune alteration during successful HAART.
Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
[TBL] [Abstract][Full Text] [Related]
7. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.
Keating SM; Golub ET; Nowicki M; Young M; Anastos K; Crystal H; Cohen MH; Zhang J; Greenblatt RM; Desai S; Wu S; Landay AL; Gange SJ; Norris PJ;
AIDS; 2011 Sep; 25(15):1823-32. PubMed ID: 21572306
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
Havlir DV; Torriani FJ; Schrier RD; Huang JY; Lederman MM; Chervenak KA; Boom WH
J Clin Microbiol; 2001 Jan; 39(1):298-303. PubMed ID: 11136787
[TBL] [Abstract][Full Text] [Related]
9. Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy.
Schulbin H; Bode H; Stocker H; Schmidt W; Zippel T; Loddenkemper C; Engelmann E; Epple HJ; Arastéh K; Zeitz M; Ullrich R;
Antimicrob Agents Chemother; 2008 Sep; 52(9):3377-84. PubMed ID: 18573939
[TBL] [Abstract][Full Text] [Related]
10. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
Tornero C; Alberola J; Tamarit A; Navarro D
Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
[TBL] [Abstract][Full Text] [Related]
11. Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.
Brazille P; Dereuddre-Bosquet N; Leport C; Clayette P; Boyer O; Vildé JL; Dormont D; Benveniste O
Clin Exp Immunol; 2003 Feb; 131(2):304-11. PubMed ID: 12562393
[TBL] [Abstract][Full Text] [Related]
12. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
[TBL] [Abstract][Full Text] [Related]
13. Programmed death 1 receptor changes ex vivo in HIV-infected adults following initiation of highly active antiretroviral therapy.
Spitsin S; Tustin NB; Riedel E; Tustin R; Murray JB; Peck LM; Khan M; Quinn J; Douglas SD
Clin Vaccine Immunol; 2012 May; 19(5):752-6. PubMed ID: 22441393
[TBL] [Abstract][Full Text] [Related]
14. Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.
Camargo JF; Kulkarni H; Agan BK; Gaitan AA; Beachy LA; Srinivas S; He W; Anderson S; Marconi VC; Dolan MJ; Ahuja SK
J Infect Dis; 2009 Jun; 199(12):1872-82. PubMed ID: 19432535
[TBL] [Abstract][Full Text] [Related]
15. Plasma Levels of Secreted Cytokines in Virologically Controlled HIV-Infected Aging Adult Individuals on Long-Term Antiretroviral Therapy.
Love M; Behrens-Bradley N; Ahmad A; Wertheimer A; Klotz S; Ahmad N
Viral Immunol; 2024 May; 37(4):202-215. PubMed ID: 38717822
[TBL] [Abstract][Full Text] [Related]
16. T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens.
da Silva TP; Giacoia-Gripp CB; Schmaltz CA; Sant Anna FM; Rolla V; Morgado MG
PLoS One; 2013; 8(6):e66095. PubMed ID: 23840403
[TBL] [Abstract][Full Text] [Related]
17. Classical and alternative macrophages have impaired function during acute and chronic HIV-1 infection.
Galvão-Lima LJ; Espíndola MS; Soares LS; Zambuzi FA; Cacemiro M; Fontanari C; Bollela VR; Frantz FG
Braz J Infect Dis; 2017; 21(1):42-50. PubMed ID: 27912071
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression.
Maina EK; Abana CZ; Bukusi EA; Sedegah M; Lartey M; Ampofo WK
Cytokine; 2016 May; 81():109-16. PubMed ID: 26986868
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy.
Yong X; Liu Z; Jiang L; Tao R; Liu W; Zhang L; Peng Y; Lin X; Huang Y
Arch Oral Biol; 2018 Aug; 92():62-67. PubMed ID: 29753928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
